02633 JACOBSON PHARMA
Closed Add to Porfolio| Key Financial Ratio (Fiscal Year: 03/2025) | |||
| Current | 1.88X | Oper Margin | 26.3% |
|---|---|---|---|
| LT Debt/Equity | 20.9% | Net Margin | 19.1% |
| Total Debt/Equity | 31.5% | Return on Equity | 12.3% |
| Price/Book | 1.04X | Return on Assets | 8.3% |
| (HKD 1.270) | 2025-03 | 2024-03 | 2023-03 | 2022-03 | 2021-03 |
| Net Profit (MHKD) | 300.83 | 266.97 | 251.04 | 177.67 | 173.71 |
|---|---|---|---|---|---|
| Net Profit Growth (%) | +12.7 | +6.3 | +41.3 | +2.3 | -19.4 |
| Earnings Per Share (HKD) | 0.152 | 0.139 | 0.131 | 0.093 | 0.091 |
| Earnings Per Share Growth (%) | +9.0 | +5.9 | +41.6 | +2.2 | -16.6 |
| Dividend Per Share (HKD) | 0.150 | 0.055 | 0.052 | 0.039 | 0.023 |
| P/E* (X) | 8.38 | 9.14 | 9.67 | 13.70 | 14.00 |
| Yield (%) | 11.81 | 4.33 | 4.08 | 3.06 | 1.81 |
| Dividend Share (%) | 99.01 | 39.57 | 39.45 | 41.86 | 25.36 |
| Book NAV (HKD) | 1.227 | 1.186 | 1.435 | 1.301 | 1.248 |
| Auditors' Opinion | Unqualified | Unqualified | Unqualified | Unqualified | Unqualified |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2025-12-15 21:40:20
Latest Result
| (HKDMn) | 2025-09 | 2024-09 | Chg* (%) | 2023-09 |
| Cover Period (mths) | 6 | 6 | NA | 6 |
|---|---|---|---|---|
| Turnover | 766.553 | 810.002 | -5.4 | 957.439 |
| Operating Result | 170.566 | 176.954 | -3.6 | 210.143 |
| Associates | 3.061 | 0.129 | +2,272.9 | -0.27 |
| Profit Before Taxation | 173.535 | 175.377 | -1.1 | 211.522 |
| Taxation | 31.5 | 35.087 | -10.2 | 33.632 |
| Profit /( Loss) After Taxation | 142.035 | 140.29 | +1.2 | 177.89 |
| Minority Interests | 0 | 0 | N/A | 23.85 |
| Net Profit | 142.035 | 140.29 | +1.2 | 154.04 |
| Earnings Per Share () | 0.0712 | 0.0707 | +0.7 | 0.0806 |
| Dividend Per Share () | 0.0425 | 0.0350 | +21.4 | 0.0250 |
| Announcement Date | 2025-11-18 | 2024-11-21 | NA | 2023-11-24 |
* Annualised
Last Update Time: 2025-12-15 21:40:25
